These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20827043)

  • 1. [Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori].
    Nomura E; Uchimi K; Abue M; Kon H; Noguchi T; Suzuki S; Suzuki M; Onodera H; Tateno H; Ota Y
    Nihon Shokakibyo Gakkai Zasshi; 2010 Sep; 107(9):1466-73. PubMed ID: 20827043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regression of primary rectal MALT lymphoma after Helicobacter pylori eradication].
    Nosaka K; Shono T; Yonemura Y; Iyama K; Sasaki Y; Endo S; Okuno Y; Mitsuya H
    Rinsho Ketsueki; 2014 Aug; 55(8):948-52. PubMed ID: 25186484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case.
    Hisabe T; Imamura K; Furukawa K; Tsuda S; Matsui T; Yao T; Kanda M; Ohshima K; Kikuchi M
    Dis Colon Rectum; 2002 Sep; 45(9):1267-70. PubMed ID: 12352248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
    Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
    Nagashima R; Takeda H; Maeda K; Ohno S; Takahashi T
    Gastroenterology; 1996 Dec; 111(6):1674-8. PubMed ID: 8942749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum.
    De Sanctis V; Marignani M; Angeletti S; Assisi D; Armosini V; Valeriani M; Minniti G; Cox MC; Ruco L; Enrici RM
    Tumori; 2012; 98(4):e105-10. PubMed ID: 23052174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
    Miki H; Kobayashi S; Harada H; Yamanoi Y; Uraoka T; Sotozono M; Ohmori M
    J Gastroenterol; 2001 Feb; 36(2):121-4. PubMed ID: 11227668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients.
    Nakase H; Okazaki K; Ohana M; Ikeda K; Uchida K; Uose S; Itoh T; Iwano M; Watanabe N; Yazumi S; Kawanami C; Inoue F; Chiba T
    Endoscopy; 2002 Apr; 34(4):343-6. PubMed ID: 11932795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal MALT lymphoma regression and anti-Helicobacter pylori therapy.
    Ito Y; Ureshino H; Tsuruoka N; Noda T
    QJM; 2018 Oct; 111(10):737-738. PubMed ID: 29961825
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
    Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
    Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
    Urakami Y; Sano T; Begum S; Endo H; Kawamata H; Oki Y
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1113-9. PubMed ID: 11106089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of gastric MALT lymphoma regressed endoscopically and pathologically after eradication of Helicobacter pylori].
    Seko A; Amano K; Shimizu H; Takagi S; Goto A; Kondo H; Sugie S; Yoshimi N; Moriwaki H; Muto Y
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jan; 94(1):21-6. PubMed ID: 9028139
    [No Abstract]   [Full Text] [Related]  

  • 14. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
    Huang YK; Wu MC; Wang SS; Kuo CH; Lee YC; Chang LL; Wang TH; Chen YH; Wang WM; Wu DC; Kuo FC
    J Dig Dis; 2012 Apr; 13(4):232-8. PubMed ID: 22435509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
    Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
    Kato A; Kato H; Hirashima N; Sakamoto T; Nukaya H; Ito K; Matsunaga S; Kondo H; Tanaka Y; Sakakibara K
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1209-16. PubMed ID: 15570869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of MALT lymphoma of the rectum after anti-H. pylori therapy in a patient negative for H. pylori.
    Inoue F; Chiba T
    Gastroenterology; 1999 Aug; 117(2):514-5. PubMed ID: 10465640
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.